title: [Who is to be vaccinated against cervix cancer and when? Proposal to counseling points].
authors.affiliation: bjorn.strander@swipnet.se
authors.forename: Strander
authors.initials: S
authors.lastname: Björn
authors.forename: Andrae
authors.initials: A
authors.lastname: Bengt
authors.forename: Elfgren
authors.initials: E
authors.lastname: Kristina
mesh_terms: D000293:Adolescent; D002648:Child; D005260:Female; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage*; D017410:Practice Guidelines as Topic; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control* / Q000821:virology
chemical_list: D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines